Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > EBITDA

Arbutus Biopharma Cp EBITDA Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly EBITDA from 2010 to 2018. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Arbutus Biopharma Cp EBITDA for the quarter ending December 12, 2018 was $-15m a -5.44% increase of 1m year over year
  • Arbutus Biopharma Cp EBITDA for the last 12 months ending December 12, 2018 was $-68m a 8.30% decrease of -6m year over year
  • Arbutus Biopharma Cp Annual EBITDA for 2018 was $-68m a 5.69% decrease of -4m from 2017
  • Arbutus Biopharma Cp Annual EBITDA for 2017 was $-64m a -4.84% increase of 3m from 2016
  • Arbutus Biopharma Cp Annual EBITDA for 2016 was $-67m a 24.90% decrease of -17m from 2015
Other Income Statement Metrics:
  • Arbutus Biopharma Cp Net Income for the quarter ending December 12, 2018 was $-18m a 4.70% decrease of -1m year over year
  • Arbutus Biopharma Cp Total Revenue for the quarter ending December 12, 2018 was $2m a 12.06% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS EBITDA Data

12/2018$-15m
09/2018$-18m
06/2018$-19m
03/2018$-16m
12/2017$-23m
09/2017$-12m
06/2017$-19m
03/2017$-18m
12/2016$-19m
09/2016$-16m

Annual ABUS EBITDA Data

2018$-68m
2017$-64m
2016$-67m
2015$-50m
2014$-32m
2013$-12m
2012$-12m
2011$-10m
2010$-6m
2009$-7m